AU2007263393B2 - Polymorphic forms and process - Google Patents
Polymorphic forms and process Download PDFInfo
- Publication number
- AU2007263393B2 AU2007263393B2 AU2007263393A AU2007263393A AU2007263393B2 AU 2007263393 B2 AU2007263393 B2 AU 2007263393B2 AU 2007263393 A AU2007263393 A AU 2007263393A AU 2007263393 A AU2007263393 A AU 2007263393A AU 2007263393 B2 AU2007263393 B2 AU 2007263393B2
- Authority
- AU
- Australia
- Prior art keywords
- formula
- naryl
- nnr
- phenyl
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06012525.9 | 2006-06-19 | ||
| EP06012525 | 2006-06-19 | ||
| PCT/EP2007/004711 WO2007147480A2 (en) | 2006-06-19 | 2007-05-26 | Polymorphic forms and process |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2007263393A1 AU2007263393A1 (en) | 2007-12-27 |
| AU2007263393B2 true AU2007263393B2 (en) | 2012-03-01 |
Family
ID=38687475
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2007263393A Ceased AU2007263393B2 (en) | 2006-06-19 | 2007-05-26 | Polymorphic forms and process |
Country Status (19)
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102005027170A1 (de) * | 2005-06-13 | 2006-12-14 | Merck Patent Gmbh | Substituierte Tetrahydrochinoline |
| DE102007021862A1 (de) * | 2007-05-10 | 2008-11-13 | Merck Patent Gmbh | Wässrige pharmazeutische Zubereitung |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2004309028A1 (en) * | 2003-12-20 | 2005-07-14 | Merck Patent Gmbh | 2-(hetero)-aryl-substituted tetrahydroquinoline derivatives |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3345355A1 (de) * | 1983-12-15 | 1985-06-27 | Hoechst Ag, 6230 Frankfurt | Verfahren zur racematspaltung bicyclischer imino-(alpha)-carbonsaeureester |
| DE4203547A1 (de) * | 1992-02-07 | 1993-08-12 | Knoll Ag | Verfahren zur racemattrennung von verapamil |
| JPH07247286A (ja) * | 1994-01-18 | 1995-09-26 | Sankyo Co Ltd | 含窒素環状化合物の光学分割方法 |
| JPH07330732A (ja) * | 1994-06-10 | 1995-12-19 | Kyorin Pharmaceut Co Ltd | 光学活性な3−アミノ−1−ベンジルピペリジン誘導体 |
| GB0010437D0 (en) * | 2000-04-28 | 2000-06-14 | Darwin Discovery Ltd | Process |
| US20040002615A1 (en) * | 2002-06-28 | 2004-01-01 | Allen David Robert | Preparation of chiral amino-nitriles |
-
2007
- 2007-05-26 KR KR1020097000904A patent/KR20090020702A/ko not_active Withdrawn
- 2007-05-26 US US12/305,524 patent/US8198452B2/en not_active Expired - Fee Related
- 2007-05-26 EP EP07725607.1A patent/EP2032581B1/en not_active Not-in-force
- 2007-05-26 EA EA200802400A patent/EA015994B1/ru not_active IP Right Cessation
- 2007-05-26 AU AU2007263393A patent/AU2007263393B2/en not_active Ceased
- 2007-05-26 JP JP2009515726A patent/JP5322928B2/ja not_active Expired - Fee Related
- 2007-05-26 NZ NZ574236A patent/NZ574236A/en not_active IP Right Cessation
- 2007-05-26 MX MX2008016071A patent/MX2008016071A/es not_active Application Discontinuation
- 2007-05-26 WO PCT/EP2007/004711 patent/WO2007147480A2/en not_active Ceased
- 2007-05-26 CA CA2656064A patent/CA2656064C/en not_active Expired - Fee Related
- 2007-05-26 CN CNA2007800223205A patent/CN101472928A/zh active Pending
- 2007-05-26 BR BRPI0712393-0A patent/BRPI0712393A2/pt not_active IP Right Cessation
- 2007-05-26 ES ES07725607.1T patent/ES2537759T3/es active Active
- 2007-06-15 PE PE2007000758A patent/PE20080337A1/es not_active Application Discontinuation
- 2007-06-15 AR ARP070102629A patent/AR061379A1/es unknown
- 2007-06-15 TW TW096121905A patent/TW200815453A/zh unknown
-
2008
- 2008-12-10 IL IL195844A patent/IL195844A0/en unknown
-
2009
- 2009-01-16 ZA ZA200900383A patent/ZA200900383B/xx unknown
- 2009-01-16 EC EC2009009077A patent/ECSP099077A/es unknown
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2004309028A1 (en) * | 2003-12-20 | 2005-07-14 | Merck Patent Gmbh | 2-(hetero)-aryl-substituted tetrahydroquinoline derivatives |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2007147480A3 (en) | 2008-05-08 |
| AR061379A1 (es) | 2008-08-20 |
| EP2032581A2 (en) | 2009-03-11 |
| PE20080337A1 (es) | 2008-04-25 |
| WO2007147480A2 (en) | 2007-12-27 |
| JP2009541231A (ja) | 2009-11-26 |
| EA200802400A1 (ru) | 2009-06-30 |
| ZA200900383B (en) | 2010-01-27 |
| KR20090020702A (ko) | 2009-02-26 |
| BRPI0712393A2 (pt) | 2012-10-16 |
| NZ574236A (en) | 2010-11-26 |
| TW200815453A (en) | 2008-04-01 |
| US20090176820A1 (en) | 2009-07-09 |
| EA015994B1 (ru) | 2012-01-30 |
| ES2537759T3 (es) | 2015-06-11 |
| CA2656064C (en) | 2013-11-05 |
| JP5322928B2 (ja) | 2013-10-23 |
| MX2008016071A (es) | 2009-01-15 |
| CA2656064A1 (en) | 2007-12-27 |
| ECSP099077A (es) | 2009-02-27 |
| EP2032581B1 (en) | 2015-03-11 |
| CN101472928A (zh) | 2009-07-01 |
| US8198452B2 (en) | 2012-06-12 |
| IL195844A0 (en) | 2009-09-01 |
| AU2007263393A1 (en) | 2007-12-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8003787B2 (en) | Sulphoximine-substituted quinoline and quinazoline derivatives as kinase inhibitors | |
| TW202532417A (zh) | Kras g12c突變蛋白嘧啶並噻喃二酮類抑制劑的製備及其應用 | |
| CN113683614B (zh) | 用于治疗正粘病毒感染的稠合三环哒嗪酮化合物 | |
| WO2001021206A1 (en) | PREVENTIVES OR REMEDIES FOR MYOCARDITIS, DILATED CARDIOMYOPATHY AND CARDIAC INSUFFICIENCY CONTAINING NF-λB INHIBITORS AS THE ACTIVE INGREDIENT | |
| CN116964044B (zh) | 乙酰胺基-苯基四唑衍生物及其使用方法 | |
| WO2024002210A1 (zh) | 一种芳香酰胺类衍生物及其在抗肿瘤药物中的应用 | |
| CN114685520B (zh) | 三并环化合物及其药物组合物和应用 | |
| AU2007263393A1 (en) | Polymorphic forms and process | |
| EP1212321B1 (en) | Intermediates for the production of naphthyridine-3-carboxylic acid derivatives | |
| EP1214321B1 (en) | Process for production of naphthyridine-3-carboxylic acid derivatives | |
| CN104684894A (zh) | 吡咯烷类 | |
| JP2016505584A (ja) | ダウン症候群及びアルツハイマー病に関連する認知欠損の治療のための、dyrk1aタンパク質阻害剤としての3,5−ジアリールアザインドール類 | |
| CN109476650A (zh) | 五元杂环类化合物及其制备方法、药物组合物和用途 | |
| JP5236743B2 (ja) | テトラヒドロキノリン誘導体の調製方法 | |
| JP7106563B2 (ja) | ナフトフラン誘導体、その調製、および使用方法 | |
| HK1135380A (en) | Polymorphic forms and process | |
| TW202527947A (zh) | 芳香醯肼類衍生物及其醫藥用途 | |
| CN117777093A (zh) | 一种用于制备GnRH1R激动剂的小分子化合物 | |
| CN114380841A (zh) | 作为akt抑制剂的三环喹唑啉或二氢喹唑啉化合物 | |
| WO2019141095A1 (zh) | 脒类和胍类衍生物、其制备方法及其在医药上的应用 | |
| HK40009791B (en) | Fused tricyclic pyridazinone compounds useful to treat orthomyxovirus infections | |
| HK1251221B (en) | Tricyclic 4-pyridone-3-carboxylic acid derivatives for the treatment and prophylaxis of hepatitis b virus infection |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGA | Letters patent sealed or granted (standard patent) | ||
| MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |